PTEN and non-small cell lung carcinoma: It is suggested that miR-92a is upregulated in non-small cell lung cancer (NSCLC), which could promote growth, metastasis, and chemoresistance of NSCLC cells by targeting phosphatase and tensin homolog (PTEN) [29].